VeriMomБезопасен ли oligopeptide-62 при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety assessment was identified for oligopeptide-62, and no peer-reviewed animal or human reproductive toxicity studies were found in the literature reviewed. As a short peptide ingredient with no evidence of systemic reproductive mechanism, default low-hazard rating is applied (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- Безопасен ли oligopeptide-62 при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety assessment was identified for oligopeptide-62, and no peer-reviewed animal or human reproductive toxicity studies were found in the literature reviewed. As a short peptide ingredient with no evidence of systemic reproductive mechanism, default low-hazard rating is applied (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG).
- Безопасен ли oligopeptide-62 при грудном вскармливании?
- There are no data indicating reproductive or lactation-specific toxicity, no regulatory or peer-reviewed reports of effects on breastfeeding or milk transfer for oligopeptide-62, and no harmonised classifications (ECHA Annex VI). By default and in absence of evidence, hazard and mechanism scores are 0; expected systemic exposure from typical topical cosmetic use is negligible. Sources searched: SCCS/CIR, PubMed, PubChem, CosIng, EWG.
- Безопасен ли oligopeptide-62 для кожи малыша?
- No infant-specific safety data were identified. Hazard/mechanism remain 0 due to lack of reproductive/toxicological evidence; exposure score is increased to 1 for baby skin because infants have a more permeable stratum corneum and higher surface-area-to-weight ratio, so measurable percutaneous absorption cannot be excluded for a low‑molecular‑weight peptide. No harmonised CLP or regulatory contraindication was found. Sources searched: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Как VeriMom оценивает oligopeptide-62?
- VeriMom оценивает oligopeptide-62 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы oligopeptide-62 при беременности?
- См. наш список безопасных альтернатив oligopeptide-62 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.